Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128472) titled 'Evaluation of IL 12B Genetic Polymorphism (rs3213094)' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: South Valley University
Condition:
Psoriasis
Intervention:
Drug: Humira
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 1, 2025
Target Sample Size: 40
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128472
Published by HT Digital Content Services with permission from Health Daily Digest....